AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

BACKGROUND: Aldo-keto reductase family 1 member C3 (AKR1C3) is a key steroidogenic enzyme that is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). The aim of this study was to investigate the correlation between the express...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuantong, Zhao, Lijing, Zhang, Haitao, Liu, Xichun, Zhao, Lijuan, Zhao, Xuejian, Li, Yi, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939640/
https://www.ncbi.nlm.nih.gov/pubmed/24571686
http://dx.doi.org/10.1186/1746-1596-9-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939640/
https://www.ncbi.nlm.nih.gov/pubmed/24571686
http://dx.doi.org/10.1186/1746-1596-9-42

Ejemplares similares